{"id":766,"date":"2024-07-31T16:37:33","date_gmt":"2024-07-31T14:37:33","guid":{"rendered":"https:\/\/www.pilotunit.com\/tascmar\/?post_type=pu-partners&#038;p=766"},"modified":"2024-07-31T16:37:53","modified_gmt":"2024-07-31T14:37:53","slug":"crelux","status":"publish","type":"pu-partners","link":"https:\/\/www.pilotunit.com\/tascmar\/partners\/crelux\/","title":{"rendered":"Crelux"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull has-global-padding is-layout-constrained wp-container-core-group-is-layout-aca708c6 wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\" style=\"border-bottom-color:var(--wp--preset--color--contrast-60);border-bottom-width:1px;padding-top:var(--wp--preset--spacing--md);padding-bottom:var(--wp--preset--spacing--md)\"><h3 class=\"wp-block-heading bsaweb-toc-content__target\" id=\"partner-description\">Partner Description<\/h3><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">CRELUX GmbH is a fully independent integrated drug discovery solutions company located in Munich, Germany. The company is led by its founders and owners and provides solutions in protein production, in-vitro-activity and binding assays and X-ray crystallography.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>i2C<\/strong>\u00a0is a joint venture between CRELUX and 4SC Discovery GmbH to provide an integrated drug discovery platform (idea to candidate) which offers a seamless process from early concept through to a preclinical development candidate ready to advance into formal animal model testing and thereafter into clinical trails.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>i2C<\/strong>, CRELUX and 4SC Discovery are operating from shared facility where 4SC Discovery adds strong in silico screening and medicinal chemistry capacities, as well as a team of experienced pharmacologists that has successfully brought a number of small molecule drugs from discovery to clinical trials.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\" style=\"border-bottom-color:var(--wp--preset--color--contrast-60);border-bottom-width:1px;padding-top:var(--wp--preset--spacing--md);padding-bottom:var(--wp--preset--spacing--md)\"><h3 class=\"wp-block-heading bsaweb-toc-content__target\" id=\"role\">Role<\/h3><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">CRELUX leads\u00a0<a href=\"https:\/\/www.pilotunit.com\/tascmar\/projects\/work-package-3-anti-ageing-and-angiogenesis-bioassays\/\" data-type=\"page\" data-id=\"332\">Work Package 3<\/a>\u00a0(anti-ageing and angiogensis bioassays) and will also be involved in\u00a0<a href=\"https:\/\/www.pilotunit.com\/tascmar\/projects\/work-package-6-industrial-developments\/\" data-type=\"page\" data-id=\"349\">WP6<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.pilotunit.com\/tascmar\/projects\/work-package-8-management-and-dissemination\/\" data-type=\"page\" data-id=\"359\">WP8<\/a>.<\/p>\n<\/div>\n<\/div>\n","protected":false},"featured_media":0,"template":"wp-custom-template-sidebar-page-partners","meta":{"_acf_changed":true,"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[]},"pu-partners-category":[],"class_list":["post-766","pu-partners","type-pu-partners","status-publish","hentry"],"acf":{"link":"https:\/\/www.pilotunit.com\/tascmar\/partners\/crelux","contact_name":"Michael SCHAEFFER","contact_job_position":"Executive Director Business and Strategy, CRELUX","contact_job_position_2":"","contact_adress":" Crelux GmBH \u2013 am Klopfersitz 19a \u2013 82132 Martinsried \u2013 Germany","contact_phone":"+49 163 7007617","contact_mail":"schaeffer@crelux.com","contact_picture":770,"contact_picture_alt":"Michael SCHAEFFER","partner_logo":769,"partner_logo_alt":"Crelux logo"},"_links":{"self":[{"href":"https:\/\/www.pilotunit.com\/tascmar\/wp-json\/wp\/v2\/pu-partners\/766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pilotunit.com\/tascmar\/wp-json\/wp\/v2\/pu-partners"}],"about":[{"href":"https:\/\/www.pilotunit.com\/tascmar\/wp-json\/wp\/v2\/types\/pu-partners"}],"wp:attachment":[{"href":"https:\/\/www.pilotunit.com\/tascmar\/wp-json\/wp\/v2\/media?parent=766"}],"wp:term":[{"taxonomy":"pu-partners-category","embeddable":true,"href":"https:\/\/www.pilotunit.com\/tascmar\/wp-json\/wp\/v2\/pu-partners-category?post=766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}